UT-MD Anderson Cancer Center: AACR - New CAR T Cell Therapy Benefits Patients With Advanced Thyroid Cancers
April 29, 2025
April 29, 2025
HOUSTON, Texas, April 29 -- The University of Texas MD Anderson Cancer Center issued the following news release:
* * *
AACR: New CAR T cell therapy benefits patients with advanced thyroid cancers
* Phase I trial demonstrates lasting responses and encouraging safety profile in two aggressive thyroid cancer subtypes, suggesting further progress for CAR T cell therapy in solid tumors
* One patient experienced a complete response, and one patient h . . .
* * *
AACR: New CAR T cell therapy benefits patients with advanced thyroid cancers
* Phase I trial demonstrates lasting responses and encouraging safety profile in two aggressive thyroid cancer subtypes, suggesting further progress for CAR T cell therapy in solid tumors
* One patient experienced a complete response, and one patient h . . .